A model informed approach to assess the risk of checkpoint inhibitors induced myocarditis
Immune checkpoint inhibitors (ICIs), as a novel immunotherapy, are designed to modulate the immune system to attack malignancies. Despite their promising benefits, immune-related adverse events (IRAEs) may occur, and incidences are bound to increase with surging demand of this class of drugs in trea...
Egile Nagusiak: | ven der Vegt, S, Wang, Y, Polonchuk, L, Wang, K, Waters, S, Baker, RE |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Frontiers Media
2022
|
Antzeko izenburuak
-
Mathematical modelling of autoimmune myocarditis and the effects of immune checkpoint inhibitors
nork: van der Vegt, S, et al.
Argitaratua: (2022) -
Mathematical modelling of autoimmune myocarditis and the effects of immune checkpoint inhibitors
nork: van der Vegt, SA
Argitaratua: (2022) -
Clozapine-Induced Myocarditis and Pericarditis
nork: Othman, Zahiruddin, et al.
Argitaratua: (2014) -
Post-vaccine myocarditis: a risk worth the reward?
nork: Raman, B, et al.
Argitaratua: (2022) -
Characterising peripheral responses to immune checkpoint inhibitors
nork: Cooper, R
Argitaratua: (2021)